1. Home
  2. AWRE vs GBIO Comparison

AWRE vs GBIO Comparison

Compare AWRE & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

N/A

Current Price

$1.94

Market Cap

41.4M

Sector

Technology

ML Signal

N/A

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.69

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
GBIO
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
36.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AWRE
GBIO
Price
$1.94
$5.69
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
28.4K
89.9K
Earning Date
03-04-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
N/A
52 Week Low
$1.37
$3.00
52 Week High
$2.95
$9.96

Technical Indicators

Market Signals
Indicator
AWRE
GBIO
Relative Strength Index (RSI) 43.56 56.21
Support Level $1.81 $5.41
Resistance Level $1.98 $5.72
Average True Range (ATR) 0.09 0.13
MACD 0.01 0.01
Stochastic Oscillator 33.33 85.37

Price Performance

Historical Comparison
AWRE
GBIO

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: